Dr. Xiaoxiao Li is an Assistant Professor in the Electrical and Computer Engineering Department at the University of British Columbia (UBC), with joint appointments in Computer Science (Associate Member) and the School of Medicine at Yale University (Adjunct Assistant Professor). She is also a Canada CIFAR AI Chair and Canada Research Chair (Tier II) in Responsible AI. Her research focuses on enhancing trustworthiness, fairness, and efficiency in AI algorithms and foundation models, particularly in healthcare applications. Education: B.S. (Honors) in Zhejiang University (2015), Ph.D. in Biomedical Engineering from Yale University (2020), Postdoc at Princeton University (2020-2021). She leads the Trusted and Efficient AI (TEA) Lab at UBC, which develops algorithms for federated learning, medical imaging analysis, and interpretable AI systems. Research interests include federated learning, generative models, medical image analysis, AI fairness, and graph-based methods for neuroimaging. Recent projects include GMValuator (data valuation for generative models), FairMedFM (fairness benchmarking in medical AI), and FedTextGrad (textual gradient-based FL optimization). Grants: Canada Foundation for Innovation Grant (2023), UBC Green Lab Fund (2023), Vector Institute funding Teaching: Courses on machine learning, federated learning, and AI ethics at UBC Awards & Recognition: Best Paper Award at FL@FM WWW 2024, Editorial Board Member of Medical Image Analysis , multiple top-tier conference acceptances (NeurIPS, ICLR, CVPR, MICCAI). Lab & Teams: TEA Lab collaborates with industry and hospitals to translate AI research into clinical tools. Current projects address AI fairness in healthcare, federated learning for medical data, and multimodal medical analytics.
Dr. Hiren Patel is a Professor in the Department of Electrical and Computer Engineering at the University of Waterloo. He holds a Doctorate in Computer Engineering from Virginia Tech and previously worked as a postdoctoral fellow at UC Berkeley under Edward A. Lee. His research focuses on real-time embedded systems, computer architecture, machine learning hardware, and cybersecurity. He teaches courses like ECE 150 (Programming), ECE 320/429 (Computer Architecture), and ECE 327 (Digital Systems). Research Interests: Cyber-physical systems and hybrid architectures Hardware/software co-design methodologies Predictable cache coherence protocols IoT and edge computing systems Security in embedded and real-time systems Recent work emphasizes cache coherence solutions for safety-critical systems and GPU acceleration strategies. His publications address challenges in multicore predictability, FPGA bandwidth optimization, and autonomous robotics orchestration. No specific awards are listed, though his extensive publication record indicates significant contributions to embedded systems research. He currently oversees graduate student applications focusing on his core research areas.
Professor Matthias Mann is a world-leading scientist serving as Director of the Proteomics and Signal Transduction department at the Max Planck Institute of Biochemistry in Martinsried, Germany, and Director of the Proteomics department at the Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark. With an h-index exceeding 277 and over 350,000 citations, he is recognized as the highest cited German researcher and one of the most influential scientists globally in proteomics. His educational background includes: Ph.D. in Chemical Engineering from Yale University (1988) Master's Degree in Physics from Georg August University Göttingen (1984) Bachelor's of Arts in Mathematics from Georg August University Göttingen (1982) Professor Mann's research focuses on advancing mass spectrometry-based proteomics to understand biological systems at the protein level. His work spans technological developments in mass spectrometry, bioinformatics and computational analysis, signal transduction and posttranslational modifications, and clinical proteomics applications for disease diagnosis and treatment. The Mann lab has pioneered groundbreaking methods like SILAC for quantitative proteomics and MaxQuant for proteome data analysis. Their vision is to translate proteomics knowledge into clinical practice for predictive, diagnostic, and preventive medicine, with recent work focusing on AI-guided platforms for analyzing proteomes from minimal tissue samples. Analysis of Professor Mann's recent publications reveals a strong trend toward clinical applications of proteomics, particularly in cancer research, metabolic diseases, and neurodegenerative disorders. His work increasingly integrates spatial proteomics, single-cell resolution techniques, and artificial intelligence approaches to uncover disease mechanisms and identify potential biomarkers, with a clear shift from basic technology development toward direct clinical applications and personalized medicine. Professor Mann has received numerous prestigious awards throughout his career: 2025: Elected member of the American National Academy of Sciences 2024: Dr. H.P. Heineken Award for Biochemistry and Biophysics 2023: Otto Warburg Medal 2019: Nominated member of the Bavarian Academy of Sciences 2013: Elected member of Leopoldina German National Academy of Sciences 2012: Körber European Science Award, Louis-Jeantet Foundation Prize for Medicine, Ernst Schering Prize, and Leibniz Prize Professor Mann leads a highly collaborative research team involved in multiple international networks including the Bill & Melinda Gates Foundation, Michael J. Fox Foundation for Parkinson's Research, CLINSPECT-M, and Munich Heart Alliance. His lab has mentored numerous successful researchers, with several former postdocs receiving prestigious ERC Starting Grants. The Mann group has developed innovative clinical proteomics pipelines for analyzing archived tissue specimens and body fluids, aiming to identify protein markers for early detection of diseases such as diabetes and cancer. The Mann lab operates across two major research centers with state-of-the-art mass spectrometry facilities. Their Clinical Knowledge Graph platform integrates multi-omics data with extensive metadata, creating an ecosystem for machine learning applications in proteomics. Current research focuses on developing highly sensitive methods that can profile thousands of proteins from minimal cell samples, enabling the identification of critical disease-related proteins and supporting the development of individualized therapies.
Amy R. Wu serves as Associate Professor in Mechanical and Materials Engineering at Queen's University and holds the Mitchell Professorship in Bio-inspired Robotics. She leads the Biomechanics x Robotics Laboratory (BxRL) and contributes to the Ingenuity Labs Research Institute. Her academic credentials include: Ph.D. in Mechanical Engineering, University of Michigan Postdoctoral Research, Biorobotics Laboratory, EPFL, Switzerland Dr. Wu's research bridges biomechanics and robotics to enhance legged mobility through innovations in human-robot interaction , exoskeleton design , and gait assistance . Her work focuses on developing robotic systems that adapt to human movement patterns, particularly for spinal cord injury rehabilitation and stability augmentation during walking. Analysis of her 2019-2023 publications reveals consistent advancement in exoskeleton control algorithms, gait stability metrics, and human adaptation studies. Key trends include modular exoskeleton systems (Symbitron), neuromuscular controllers for ankle assistance, and haptic feedback integration for motor learning enhancement. No scientific awards are documented in the provided materials. Dr. Wu mentors graduate students through BxRL, where her team conducts human subject testing and robotic development. Research is supported by institutional resources at Ingenuity Labs, though specific grant details remain unspecified. The Biomechanics x Robotics Laboratory operates within Queen's Ingenuity Labs Research Institute, facilitating interdisciplinary collaboration on projects like outdoor stability assessment, winter walking adaptations, and teleoperation interfaces for drone control.
Takako Fujioka is an Associate Professor of Music at Stanford University, affiliated with the Center for Computer Research in Music and Acoustics (CCRMA). Her research focuses on the neural mechanisms underlying auditory perception, auditory-motor coupling, and music-supported therapy for neurorehabilitation. She holds a Ph.D. in Physiology from the Graduate University for Advanced Studies, Japan, and M.Sc./B.Eng. degrees in Electrical Engineering from Waseda University. Her work combines neurophysiological techniques such as MEG and EEG to study brain plasticity in development, aging, and stroke recovery. Notable contributions include investigating how music influences motor and cognitive recovery in stroke patients, as well as exploring the neural basis of musical perception through rhythmic synchronization and pitch discrimination studies. Supported by awards from the Canadian Institutes of Health Research during her postdoctoral work at the Rotman Research Institute, her research bridges clinical neuroscience and music cognition. Dr. Fujioka’s expertise spans auditory neuroscience, neurorehabilitation, and technology-assisted music therapy. She has pioneered studies on tactile mapping for cochlear implant users and networked music performance systems, emphasizing cross-modal perception and human-technology interaction. Her findings contribute to both theoretical understanding of auditory processing and practical applications in medical and educational settings. Awards: Canadian Institutes of Health Research Awards (postdoctoral phase) Labs/Teams: CCRMA, Stanford Music Perception Laboratory, Rotman Research Institute collaborations Key Themes: Neuroplasticity, Music-Mediated Rehabilitation, Auditory-Motor Integration, Multisensory Processing Her recent work examines aging-related changes in binaural hearing and the role of beta/gamma oscillations in rhythmic processing. She advocates for translational research that connects neural mechanisms with real-world therapeutic interventions.
Tianxi Cai, ScD, holds the John Rock Professorship in Population and Translational Data Sciences at the Harvard T.H. Chan School of Public Health and is a Professor of Biomedical Informatics at Harvard Medical School. She directs the Translational Data Science Center for a Learning Health System (CELEHS). Her work bridges clinical and basic science data to advance personalized medicine and disease understanding. Institution: Harvard University Departments: Biostatistics (T.H. Chan School) and Biomedical Informatics (HMS) Key Roles: Faculty member since 2002, NIH-funded researcher, and leader in EHR data analytics Research focuses on biomarker evaluation, predictive modeling, high-dimensional data analysis, and survival analysis. Collaborates with the I2B2 Center to integrate clinical and genomic data. Active in developing semi-supervised learning methods for noisy EHR data and real-world evidence generation. Funding : Recent grants include NIH projects on rheumatoid arthritis treatment response (R01AR080193, R21AR078339) and semi-supervised EHR denoising (R01LM013614). Co-leads initiatives on chronic disease endpoints using multi-source data (U01FD007929). Labs/Teams : Directs CELEHS and leads the Cai Lab, focusing on translational data science and machine learning applications in healthcare.
John D. Murray is the Gregg L. Engles Associate Professor of Psychological and Brain Sciences at Dartmouth College and an Adjunct Associate Professor of Psychiatry at Yale School of Medicine. He holds a PhD in Physics from Yale University (2013) and a BS in Physics and Mathematics from Yale (2006). His research focuses on computational neuroscience and computational psychiatry, with secondary appointments in Physics and Neuroscience at Yale until 2023. His work integrates computational modeling, neuroimaging, and systems neuroscience to study decision-making processes, cortical organization, and psychiatric disorders. Collaborators include prominent researchers like Dr. John Krystal and Dr. Anticevic. Research interests include hierarchical brain organization, neuroimaging analysis techniques, and pharmacological effects on neural circuits. His lab (Murray Lab) develops computational tools like PsychRNN for cognitive task modeling. Notable contributions include linking transcriptomic data to neuroimaging patterns and modeling LSD’s effects on brain topography. He has been featured in YaleNews and Nature Communications for innovations in mapping mental illness variability and neural circuit dynamics. Grants and collaborations span translational neuroscience, addiction, and PTSD research through partnerships with Yale’s Center for Biomedical Data Science and VA National Center for PTSD. His interdisciplinary approach bridges physics, computer science, and clinical psychiatry to advance understanding of brain function and dysfunction.
Dr. George Stamou is a Professor at the School of Electrical and Computer Engineering of the National Technical University of Athens (NTUA), serving as Director of the Artificial Intelligence and Learning Systems Laboratory (AILS). His expertise spans knowledge representation, machine learning, neural networks, and semantic technologies. He leads interdisciplinary initiatives such as the postgraduate program 'Data Science and Machine Learning' (2018–2022). Research Interests: Focuses on knowledge graphs, interpretable AI, semantic web applications, and multimodal learning. His work integrates formal logic systems (e.g., description logics) with modern deep learning techniques, addressing challenges in explainability, bias detection, and ethical AI applications. Publications: Over 150 articles in AI journals/conferences with an h-index of 34 (Google Scholar). Notable contributions include datasets like CHORDONOMICON (music analysis), GOSt-MT (gender bias in MT), and methodologies for counterfactual explanations in machine learning. Awards & Committees: Active in W3C and RuleML standardization bodies. Co-organized major AI conferences. Recognized for contributions to semantic interoperability and knowledge-based systems. Labs & Teams: Directs AILS-NTUA lab and collaborates with CISRI (Computer & Information Systems Research Institute). Engages in EU projects like CultureLabs (cultural heritage digitalization) andsmarty4covid (health data analysis).
Dr. Kenneth Joseph is an Associate Professor in the Department of Computer Science and Engineering at the University at Buffalo , part of the School of Engineering and Applied Sciences . He serves as Associate Director of the Institute for Artificial Intelligence and Data Science and leads the Computation and Equity Lab (cubelab) , focusing on social inequality through computational measures and models. Education: PhD, MS, and BS in Societal Computing from Carnegie Mellon University (2016, 2012, 2010) Research Interests: Computational Social Science, Network Science, Gender Studies, and AI for Social Good Notable Work: Gender disparities in academia, predictive modeling for foster care and urban policy, and social media rumor analysis Awards: UB Exceptional Scholar—Young Investigator Award (2021) Advising: Mentored students like Yuhao Du, Jason Yan, Arjunil Pathak, and Navid Madani on projects spanning Twitter bios, foster youth services, and algorithmic fairness.
William Yang Wang serves as the Mellichamp Professor of Artificial Intelligence at the University of California, Santa Barbara (2019-present). He directs the UCSB Center for Responsible Machine Learning, the Mind and Machine Intelligence Initiative, and the UCSB NLP Group. His research focuses on theoretical foundations and practical algorithms for AI, particularly in NLP, LLMs, and neuro-symbolic reasoning. PhD in Computer Science from Carnegie Mellon University Active in AI theory and applications (2016-present) Research interests span multiple AI domains, with special emphasis on NLP and responsible machine learning. He has pioneered datasets like HybridQA, TabFact, and VaTeX, enabling advancements in multi-hop QA, fact verification, and video-language tasks. His work combines statistical relational learning with modern deep learning paradigms. Recent publications center around multimodal reasoning, knowledge graph integration, and responsible AI development. He has received numerous accolades including the IEEE SPS Pierre-Simon Laplace Award (2024) and NSF CAREER Award (2021). Karen Sparck Jones Award (2022) DARPA Young Faculty Award (2018) IBM Faculty Award Mentoring 15+ PhD and postdoc researchers who now hold positions at Microsoft Research, Amazon, Meta GenAI, and academic institutions like Arizona and Rutgers. His lab maintains active collaborations with industry partners through initiatives like ChipAgents.ai, which he founded as CEO.
Charles E. Leonard is an Associate Professor of Epidemiology at the Perelman School of Medicine , University of Pennsylvania. He holds affiliations with multiple Penn-based institutions, including the Center for Real-World Effectiveness and Safety of Therapeutics (CREST), Institute for Translational Medicine and Therapeutics, Leonard Davis Institute, Institute on Aging, and Center of Excellence in Environmental Toxicology. Additionally, he serves as a Special Government Employee at the FDA and Honorary Lecturer at Muhimbili University of Health and Allied Sciences in Tanzania. Pharmacoepidemiology Post-market prescription drug safety Causal inference methods Real-world evidence generation Environmental health impacts on chronic disease Dr. Leonard’s research focuses on generating real-world evidence to address critical gaps in drug safety, particularly for: Population health effects of drug interactions Comparative safety of antidiabetes drugs Drug-induced sudden cardiac arrest Ambient temperature extremes and chronic disease Pharmacoepidemiology methods development His work is primarily funded by the National Institutes of Health (NIH) and has been recognized through multiple awards, including the 2024 Harold I. Feldman Distinguished Scholar Award and the 2020 Elected Fellow status at the International Society for Pharmacoepidemiology. He also contributes to curriculum development and student mentoring in Penn’s Graduate Group in Epidemiology and Biostatistics. 2024 – Harold I. Feldman Distinguished Scholar Award (Penn) 2024 – Ronald D. Mann Best Paper Award (ISPE) 2020 – Leadership Medallion (BPS) 2019 – Abraham G. Hartzema Distinguished Lecturer (University of Florida)
Rosa I. Arriaga is an Associate Professor in the School of Interactive Computing at Georgia Institute of Technology, where she directs the Ubicomp Health and Wellness Lab. Her research focuses on Human-Computer Interaction (HCI), Ubiquitous Computing, and mHealth, with applications in mental health, chronic disease management (e.g., diabetes), and pediatric asthma care. She designs technology systems to improve patient engagement, continuity of care, and clinician-patient communication. Research Areas: Chronic Care Management PTSD Therapy Support (PECSS project) Diabetes Management (DUCSS project) mHealth System Design AI in Healthcare Key Projects: PECSS: Leverages ubiquitous computing and machine learning to address clinical challenges in PTSD therapy. DUCSS: A diabetes management system to streamline patient education and self-monitoring, particularly for underserved populations. ZenVR: A virtual reality system for meditation education, validated through longitudinal studies. Teaching: Teaches undergraduate courses in HCI and graduate courses in Human-Centered Computing (HCC). Her Coursera course Intro to User Experience Design has over 50K learners. Grants & Partnerships: Funded by GT-Emory AI Humanity, American Diabetes Association, and Georgia Center for Diabetes Translation Research. Collaborations with Emory University, University of Rochester, and medical professionals. Labs & Teams: Leads the Ubicomp Health and Wellness Lab, fostering interdisciplinary research with graduate and undergraduate students focusing on health technology innovation.
Mi Zhang is an Associate Professor in the Department of Computer Science and Engineering at The Ohio State University and Director of the OSU AIoT and Machine Learning Systems Lab. He holds multiple affiliations including the Institute for Cybersecurity and Digital Trust, Translational Data Analytics Institute, and 5G and Broadband Connectivity Center. Dr. Zhang received his Ph.D. from University of Southern California and B.S. from Peking University, followed by a postdoctoral position at Cornell University. His academic journey previously included a position at Michigan State University before joining OSU. His research focuses on Empowering Billions of Everyday Devices with AI to realize the Artificial Intelligence of Things (AIoT) vision. His lab works across several interconnected domains including efficient generative AI (multimodal LLMs, diffusion models), edge AI for mobile/AR/wearables, systems for AI agents, spatial computing, foundation models for IoT, and human-centered mobile health applications. This interdisciplinary work draws from mobile/edge computing, AI/machine learning, distributed systems, computer networks, and human-centered computing. Analysis of his recent publications reveals a strong focus on making AI more efficient and accessible for resource-constrained devices. His research trajectory shows increasing emphasis on large language models and their optimization for edge deployment, alongside continued work in federated learning for IoT applications. The publications demonstrate both theoretical contributions and practical applications across healthcare, wireless networks, and human-computer interaction. Best Paper Award, IEEE Internet Computing Magazine (2024) University of Chicago Outstanding Educator Award (2024) Best Paper Award, ECCV'24 Workshop (2024) USC ECE SIPI Distinguished Alumni Award (2023) Multiple Best Paper Awards from ACM/IEEE conferences NSF CRII Award Facebook/Meta Faculty Research Award Amazon Research Award MSU Innovation of the Year Award (2020) Dr. Zhang actively mentors students at all levels, with a current group of Ph.D. students working on cutting-edge AI/ML systems. His lab has secured significant funding including Meta Reality Labs Faculty Awards, NVIDIA academic grants, and NSF grants. The OSU AIoT and Machine Learning Systems Lab serves as the central hub for his research activities, fostering collaboration across multiple disciplines to advance the field of AIoT.
David S. Eisenberg is a Professor of Chemistry and Biochemistry and Biological Chemistry at the University of California, Los Angeles, where he also serves as Director of the UCLA-DOE Institute for Genomics and Proteomics and as an HHMI Investigator. His research focuses on protein interactions, particularly the structural basis for conversion of normal proteins to the amyloid state and conversion of prions to the infectious state. Dr. Eisenberg earned his undergraduate degree in biochemical sciences from Harvard College and his D.Phil. degree in theoretical chemistry from Oxford University on a Rhodes Scholarship. His postdoctoral research was on ice and water with Walter Kauzmann at Princeton and in protein crystallography with Richard Dickerson. He joined the UCLA faculty after his postdoctoral studies. Dr. Eisenberg and his research group focus on protein interactions in amyloid and prion diseases. These diseases involve protein aggregation where normal functional proteins convert to abnormal aggregated forms. Systemic amyloid diseases like dialysis-related amyloidosis result from fiber accumulation until organ failure, while neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and prion conditions appear to be caused by smaller oligomers. In 2005, his team determined the atomic-level structure for the amyloid fiber spine, revealing a 'steric zipper' of two parallel beta sheets packed across a dry interface. Since then, they've determined approximately 90 amyloid spines from 15 disease-related proteins. In 2010, they identified the structure of a toxic amyloid-related oligomer consisting of six anti-parallel beta strands forming a cylindrical barrel. His recent publications demonstrate continued innovation in amyloid research, with focus areas including structural prediction of amyloid formation, mechanisms of tau fibril disassembly in Alzheimer's disease, cryo-EM analysis of amyloid polymorphism, and structure-based design of inhibitors for amyloid toxicity. His work integrates computational, structural, and biochemical approaches to understand protein aggregation across multiple disease contexts. Dr. Eisenberg has received numerous prestigious awards and honors: National Academy of Sciences Member American Philosophical Society Member Institute of Medicine Member Howard Hughes Medical Institute Investigator Biophysical Society Emily M. Gray Award Harvard Westheimer Medal UCLA Seaborg Medal Technion - Israel Institute of Technology Harvey Prize in Human Health As Director of the UCLA-DOE Institute for Genomics and Proteomics and an HHMI Investigator, Dr. Eisenberg leads significant research initiatives in protein structure and aggregation. His laboratory combines X-ray crystallography, bioinformatics, and biochemical techniques to investigate protein interactions, with particular emphasis on amyloid-forming proteins and their role in disease. The Eisenberg Lab, located in Boyer Hall at UCLA, maintains an active research program investigating the structural basis of protein aggregation. The lab continues to build on its landmark discoveries of amyloid structures while exploring new frontiers in understanding protein misfolding diseases and developing potential therapeutic interventions.
Yanzhi Wang is a Professor in the Department of Electrical and Computer Engineering at Northeastern University , affiliated with the Institute for Experiential AI and the Institute for the Wireless Internet of Things . He holds a PhD from the University of Southern California (2014). His research focuses on real-time AI systems, deep neural network compression, neuromorphic computing, and non-von Neumann architectures. Notable projects include NSF-funded initiatives on age-inclusive urban design, superconducting computing (DISCoVER), and edge device optimization (PatDNN). He has received prestigious awards such as the Army Research Office Young Investigator Award and the Constantinos Mavroidis Translational Research Award. His work emphasizes algorithm-hardware co-design for energy efficiency, with grants from NSF, ARO, and industry partners like Google. Recent research trends reflect his focus on accelerating vision transformers, diffusion models, and large language models for edge computing. He has pioneered methods like AutoViT and Fastcar, addressing latency and resource constraints in mobile platforms. Collaborations span academia and industry, driving innovations in superconducting circuits and neuromorphic systems.
